Titlebook: GISTs - Gastrointestinal Stromal Tumors; Elisabetta Lutio di Castelguidone,Antonella Messin Book 2011 Springer Verlag Milan 2011 Gastroint

浮夸

Magnetic Resonance neoplastic lesions and to quantify the reduction In vascularity and the presence of necrosis Induced by the therapy, even In the early phase of treatment..MR Is an effective examination technique In the evaluation of GISTs, with highcontrast resolution and multlplanar capability. The most effective

震驚

Contrast-enhanced PET/CT in the Follow-up of GISTsaluation of GIST were recognized as being more predictive (in terms of TTP, time-to-progression) than the RECIST criteria. Recently an increased number of publications in the literature revealed the improved clinical use of injected PET/CT. The evaluation of tomodensitometric parameters in residual

Critical

獨白

hankering

GIST Unit Networkions or test Interpretation to support or guide care for specific patients and their follow-up, the use of a database for research (clinical trials), for epldemiologlcal purposes, as well as editorial and continuous medical education activities.

Original

Ilse Helbrecht Dipl. Geographinations..GISTs may certainly be detected with conventional radiography, but today barium examinations are no longer Indicated as first-line studies In this clinical context. The diagnosis of GIST with conventional radiography may be considered an Incidental report In clinical practice, because ultras

d-limonene

,Hahn: ?Einstellungen zum Tod“, EUS. In this case, the patient should undergo surgery without further diagnostic tests. If no signs of malignancy are detected at EUS, then strict follow-up of the lesion can be planned or EUS-FNA should be considered. However, cytological morphology and immunohistochemistry are crucial to the esta

生氣的邊緣

混合

https://doi.org/10.1007/978-3-658-17041-7aluation of GIST were recognized as being more predictive (in terms of TTP, time-to-progression) than the RECIST criteria. Recently an increased number of publications in the literature revealed the improved clinical use of injected PET/CT. The evaluation of tomodensitometric parameters in residual

chemoprevention

"Von Pol zu Pol Ges?nge sich erneun..."of 2 years from starting Imatinib, even though a proportion of advanced patients become long-term progression-free survivors. Sunitinib Is the standard second-line therapy, and new agents are under study. It Is unknown whether adjuvant complete surgery of responding residual metastases may impact th